Identification of Patients at Elevated Cancer Risk through a community‑based genetic testing program

Danielle Brabender, Emily Siegel, Julie O. Culver, et al. Ann Surg Oncol (2025) 32:9041–9049

Only a subset of individuals meeting National Comprehensive Cancer Network (NCCN) guidelines for genetic screening of hereditary cancers are being offered testing. A total of 14,192 women were screened, with 3224 (23%) meeting NCC... Read More

Mar 24, 2026

Disparities in the incidence, mortality and disability-adjusted life years of 33 early-onset cancer groups globally, 2012-2021: a systematic analysis

Wenxin Yan, Min Liu, Wenzhan Jing et al. Exp Hematol Oncol. 2025 Mar 17;14(1):38

The global cancer burden is rising, with early-onset cancers becoming more prevalent. We aimed to investigate the burden, trend and population disparity in 33 early-onset cancers from 2012 to 2021. In 2021, there were 2.65 mi... Read More

Mar 24, 2026

Global Epidemiologic Trends of Early-Onset Cancers From 1990 to 2021 and Projection to 2040

Rupayan Kundu, Ankush Mukhopadhyay, Niladri Kal, et al .JCO Glob Oncol 12, e2500170(2026). Volume 12

Early-onset cancer (EOC), defined as cancer occurring in individuals age 15-49 years, represents a growing global health burden.  In 2021, there were approximately 23.6 million new EOC cases and 0.99 million deaths globally.... Read More

Mar 24, 2026

Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

Farhad Islami MD, Emily C. Marlow, Blake Thomson, et al. CA Cancer J Clin. 2024;74:405–432

The authors estimated the proportion and number of invasive cancer cases (excluding nonmelanoma skin cancers) and deaths, overall and for 30 cancer types among adults who were aged 30 years and older in 2019 in the United States,... Read More

Mar 24, 2026

Global burden of cancer and associated risk factors in 204 countries and territories, 1980– 2021: a systematic analysis for the GBD 2021

Zenghong Wu, Fangnan Xia and Rong Li. Journal of Hematology & Oncology, (2024)

Cancer is the second most common cause of death globally.This study aimed to assess cancer burden and associated risk factors in 204 countries and territories between 1980 and 2021.Methods We selected data on cancer incidence and... Read More

Mar 23, 2026

The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023

GBD 2023 Cancer Collaborators. Lancet 2025; 406: 1565–86

Cancer is a leading cause of death globally. To inform global cancer-control efforts, we used the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 framework to generate and analyze estimates of cancer burden... Read More

Mar 16, 2026

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Mathieu LaversanneMSc, Hyuna Sung, et al. CA Cancer J Clin. 2024;74:229–263

This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC). There were close to 20 million new cases of cancer in the yea... Read More

Mar 16, 2026